Recently, this journal published a paper from Marr et al 1 concerning multi-drug intra-arterial chemotherapy (IAC) for intraocular retinoblastoma. In many centres IAC has quickly garnered exciting interest, emerging as a promising, highly effective alternative for globe conserving treatment.2–4 In our institution, IAC with melphalan (IACM) has been performed since June 2008, and topotecan was added in June 2011. Fifty-nine patients have at least 1 year follow-up. Here we report our results obtained with IACM.
|Titolo:||Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma|
|Citazione:||Bracco, S., Leonini, S., DE FRANCESCO, S., Cioni, S., Gennari, P., Vallone, I.M., et al. (2013). Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma. BRITISH JOURNAL OF OPHTHALMOLOGY, 97(9), 1219-1221.|
|Appare nelle tipologie:||1.1 Articolo in rivista|